PDF herunterladen
Tierarztl Prax Ausg K Kleintiere Heimtiere 2007; 35(02): 141-147
DOI: 10.1055/s-0038-1622612
Für Studium und Praxis
Schattauer GmbH

Das maligne Lymphom des Hundes

Übersicht und neue Therapieansätze
I. Zenker
1   Abteilung für Onkologie der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
,
J. Hirschberger
1   Abteilung für Onkologie der Medizinischen Kleintierklinik (Vorstand: Prof. Dr. K. Hartmann) der Ludwig-Maximilians-Universität München
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
05. Januar 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • Literaturf

  • 1 Blackwood L, Sullivan M, Lawson H. Radiographic abnormalities in canine multicentric lymphoma: a review of 84 cases. J Small Anim Pract 1997; 38 (02) 62-69.
    CrossrefPubMedSuche in Google Scholar
  • 2 Carlo GL, Cole P, Miller AB, Munro IC, Solomon KR, Squire RA. Review of a study reporting an association between 2,4-dichlorophenoxyacetic acid and canine malignant lymphoma: report of an expert panel. Regul Toxicol Pharmacol 1992; 16 (03) 245-252.
    CrossrefPubMedSuche in Google Scholar
  • 3 Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000; 14 (02) 120-124.
    CrossrefPubMedSuche in Google Scholar
  • 4 Dobson JM, Samuel S, Milstein H, Rogers K, Wood JL. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J SmallAnim Pract 2002; 43 (06) 240-246.
    PubMedSuche in Google Scholar
  • 5 Dorn CR, Taylor DO, Schneider R. The epidemiology of canine leukemia and lymphoma. Bibl Haematol 1970; (36) 403-415.
    PubMedSuche in Google Scholar
  • 6 Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002; 16 (06) 704-709.
    CrossrefPubMedSuche in Google Scholar
  • 7 Hayes HM, Tarone RE, Cantor KP, Jessen CR, McCurnin DM, Richardson RC. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. J Natl Cancer Inst 1991; 83 (17) 1226-1231.
    CrossrefPubMedSuche in Google Scholar
  • 8 Kessler M. Kleintieronkologie: Diagnose und Therapie von Tumorerkrankungen bei Hunden und Katzen, 2. Aufl. Stuttgart: Parey; 2005
    Suche in Google Scholar
  • 9 Laing EJ, Fitzpatrick PJ, Binnington AG, Norris AM, Mosseri A, Rider WD. et al Half-body radiotherapy in the treatment of canine lymphoma. J Vet Intern Med 1989; 3 (02) 102-108.
    CrossrefPubMedSuche in Google Scholar
  • 10 Moore AS, London CA, Wood CA, Williams LE, Cotter SML, Heureux DA. et al Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. J Vet Intern Med 1999; 13 (05) 395-398.
    CrossrefPubMedSuche in Google Scholar
  • 11 Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA. et al Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001; 15 (04) 348-354.
    CrossrefPubMedSuche in Google Scholar
  • 12 Moore PF, Olivry T, Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells. Am J Pathol 1994; 144 (02) 421-429.
    PubMedSuche in Google Scholar
  • 13 Morrison W. Cancer in Dogs and Cats: Medical and Surgical Management. 2nd ed.. Jackson, WY: Teton New Media; 2002
    Suche in Google Scholar
  • 14 Myers NC, Moore AS, Rand WM, Gliatto J, Cotter SM. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Intern Med 1997; 11 (06) 333-339.
    CrossrefPubMedSuche in Google Scholar
  • 15 Ogilvie GK, Fettman MJ, Mallinckrodt CH, Walton JA, Hansen RA, Davenport DJ. et al Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer 2000; 88 (08) 1916-1928.
    CrossrefPubMedSuche in Google Scholar
  • 16 Raskin RE, Krehbiel JD. Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma. J Am Vet Med Assoc 1989; 194 (10) 1427-1429.
    PubMedSuche in Google Scholar
  • 17 Rassnick KM, Mauldin GE, Al-Sarraf R, Mauldin GN, Moore AS, Mooney SC. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989–2000). J Vet Intern Med 2002; 16 (05) 576-580.
    PubMedSuche in Google Scholar
  • 18 Rosenberg MP, Matus RE, Patnaik AK. Prognostic factors in dogs with lymphoma and associated hypercalcemia. J Vet Intern Med 1991; 5 (05) 268-271.
    CrossrefPubMedSuche in Google Scholar
  • 19 Siedlecki CT, Kass PH, Jakubiak MJ, Dank G, Lyons J, Kent MS. Evaluation of an actinomycin- D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. Can Vet J 2006; 47 (01) 52-59.
    PubMedSuche in Google Scholar
  • 20 Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. J Vet Intern Med 2006; 20 (04) 948-954.
    CrossrefPubMedSuche in Google Scholar
  • 21 Starrak GS, Berry CR, Page RL, Johnson JL, Thrall DE. Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma. Vet Radiol Ultrasound 1997; 38 (06) 411-418.
    CrossrefPubMedSuche in Google Scholar
  • 22 Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K. et al CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med 2006; 20 (01) 136-143.
    CrossrefPubMedSuche in Google Scholar
  • 23 Zenker I. Allgemeine Aspekte der Chemotherapie in der kleintierpraxis. Tierärztl Prax 2005; 33 (K) 384-388.
    PubMedSuche in Google Scholar